0001213900-23-054606.txt : 20230705 0001213900-23-054606.hdr.sgml : 20230705 20230705140937 ACCESSION NUMBER: 0001213900-23-054606 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230705 DATE AS OF CHANGE: 20230705 EFFECTIVENESS DATE: 20230705 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroSense Therapeutics Ltd. CENTRAL INDEX KEY: 0001875091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-485926 FILM NUMBER: 231067849 BUSINESS ADDRESS: STREET 1: 11 HAMENOFIM ST. STREET 2: BUILDING B CITY: HERZLIYA STATE: L3 ZIP: 4672562 BUSINESS PHONE: 972-9-9531142 MAIL ADDRESS: STREET 1: 11 HAMENOFIM ST. STREET 2: BUILDING B CITY: HERZLIYA STATE: L3 ZIP: 4672562 D 1 primary_doc.xml X0708 D LIVE 0001875091 NeuroSense Therapeutics Ltd. 11 HAMENOFIM STREET, BUILDING B HERZLIYA L3 ISRAEL 4672562 +972-9-7996183 ISRAEL None None Corporation true Alon Ben-Noon 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Executive Officer Director Or Eisenberg 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Executive Officer Chief Financial Officer Ferenc Tracik 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Executive Officer Chief Medical Officer Hagit Binder 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Executive Officer Chief Operating Officer Niva Russek-Blum 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Executive Officer Chief Technology Officer Christine Pelizzari 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Director Caren Deardorf 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Director Revital Mandil-Levin 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Director Mark Leuchtenberger 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Director Cary Claiborne 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Director Biotechnology Decline to Disclose 06b false true true true true false 0 A.G.P. / Alliance Global Partners 8361 None None 88 POST ROAD WEST 2ND FLOOR WESTPORT CT CONNECTICUT 06880 NY NEW YORK false 4500000 4500000 0 The Company has sold 3,000,000 Ordinary Warrants to purchase Ordinary Shares at an excercise price of $1.50 per Ordinary Share. false 1 314988 0 The Company has paid a placement agent's fee equal to 7% of the aggregate purchase price of the Ordinary Shares and Pre-Funded Warrants sold in a concurrent registered direct offering. 0 false NeuroSense Therapeutics Ltd. /s/ Alon Ben-Noon Alon Ben-Noon Chief Executive Officer 2023-07-05